Stickler*
Active member
THE BRAZOSPORT NEWS
The Official Weblog for the Petrochemical Underarm of Texas
-----------
Friday, January 05, 2007
War on drugs flunks spelling test
A heretofore unknown obstacle in the war on drugs has come to light.
The drugs in this case are anabolic steroids, to which President Bush has made specific reference (I think it was the
speech where he said we were goin' back to the Moon. Sigh.)
Anyhow, the obstacle is that our lawmakers can't even spell some of the steroids that are being outlawed. And if you can't spell it, you can't enforce it.
In the tortured prose of our State Government, here's the problem:
The Official Weblog for the Petrochemical Underarm of Texas
-----------
Friday, January 05, 2007
War on drugs flunks spelling test
A heretofore unknown obstacle in the war on drugs has come to light.
The drugs in this case are anabolic steroids, to which President Bush has made specific reference (I think it was the
speech where he said we were goin' back to the Moon. Sigh.)
Anyhow, the obstacle is that our lawmakers can't even spell some of the steroids that are being outlawed. And if you can't spell it, you can't enforce it.
In the tortured prose of our State Government, here's the problem:
United States Senate Bill 2195, entitled the "Anabolic Steroid Control Act of 2004" was enacted on October 22, 2004. It went into effect 90 days after enactment, which was January 20, 2005. The bill redefined "anabolic steroid" and included a new list of steroids under the new definition. The list included two typographical errors in the chemical names of two anabolic steroids. The United States Congress corrected these errors under "Section 1180 of the Violence Against Women and Department of Justice Reauthorization Act of 2005" (Pub.L. 109-162). The Deputy Administrator of the Drug Enforcement Agency, therefore, issued a final rule on October 13, 2006 in the Federal Register , Volume 71, Number 198 replacing the chemical names for the following anabolic steroids: 13 beta-ethyl-17 beta-hydroxygon-4-en-3-one and stanozolol (17 alpha-methyl-17 beta-hydroxy-[5 alpha]-androst-2-eno[3,2-c]-pyrazole).
Pursuant to the Texas Controlled Substances Act, Health and Safety Code, §481.034(g), as amended by the 75th legislature, at least 31 days have expired since notice of the above referenced action was published, and on December 1, 2006, Charles E. Bell, M.D., Acting Commissioner of the Texas Department of State Health Services, ordered that the substances 13 beta-ethyl-17 beta-hydroxygon-4-en-3-one and stanozolol (17 alpha-methyl-17 beta-hydroxy-[5 alpha]-androst-2-eno[3,2-c]-pyrazole) be amended in Schedule III of the Texas Controlled Substances Act. Schedule III of said Act is hereby amended as shown in the January 2007 republication of the Schedules of Controlled Substances, effective 21 days after publication of this notice.
Pursuant to the Texas Controlled Substances Act, Health and Safety Code, §481.034(g), as amended by the 75th legislature, at least 31 days have expired since notice of the above referenced action was published, and on December 1, 2006, Charles E. Bell, M.D., Acting Commissioner of the Texas Department of State Health Services, ordered that the substances 13 beta-ethyl-17 beta-hydroxygon-4-en-3-one and stanozolol (17 alpha-methyl-17 beta-hydroxy-[5 alpha]-androst-2-eno[3,2-c]-pyrazole) be amended in Schedule III of the Texas Controlled Substances Act. Schedule III of said Act is hereby amended as shown in the January 2007 republication of the Schedules of Controlled Substances, effective 21 days after publication of this notice.
